These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8536360)

  • 1. Relationships between humoral factors in HIV-1-infected mothers and the occurrence of HIV infection in their infants.
    Mabondzo A; Rouvier P; Raoul H; Le Naour R; Courpotin C; Hervé F; Parnet-Mathieu F; Lasfargues G; Dormont D
    Clin Exp Immunol; 1995 Dec; 102(3):476-80. PubMed ID: 8536360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal humoral factors associated with perinatal human immunodeficiency virus type-1 transmission in a cohort from Kigali, Rwanda, 1988-1994.
    Tranchat C; Van de Perre P; Simonon-Sorel A; Karita E; Benchaïb M; Lepage P; Desgranges C; Boyer V; Trépo C
    J Infect; 1999 Nov; 39(3):213-20. PubMed ID: 10714798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal but Not Infant Anti-HIV-1 Neutralizing Antibody Response Associates with Enhanced Transmission and Infant Morbidity.
    Ghulam-Smith M; Olson A; White LF; Chasela CS; Ellington SR; Kourtis AP; Jamieson DJ; Tegha G; van der Horst CM; Sagar M
    mBio; 2017 Oct; 8(5):. PubMed ID: 29066544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing antibodies and viral characteristics in mother-to-child transmission of HIV-1.
    Scarlatti G; Leitner T; Hodara V; Halapi E; Rossi P; Albert J; Fenyö EM
    AIDS; 1993 Nov; 7 Suppl 2():S45-8. PubMed ID: 8161445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal Neutralization-Resistant Virus Variants Do Not Predict Infant HIV Infection Risk.
    Milligan C; Omenda MM; Chohan V; Odem-Davis K; Richardson BA; Nduati R; Overbaugh J
    mBio; 2016 Feb; 7(1):e02221-15. PubMed ID: 26838723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perinatal HIV-1 transmission: Fc gamma receptor variability associates with maternal infectiousness and infant susceptibility.
    Lassaunière R; Musekiwa A; Gray GE; Kuhn L; Tiemessen CT
    Retrovirology; 2016 Jun; 13(1):40. PubMed ID: 27287460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Features of HIV-1 that could influence maternal-child transmission.
    Kliks SC; Wara DW; Landers DV; Levy JA
    JAMA; 1994 Aug; 272(6):467-74. PubMed ID: 8040983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal Humoral Immune Correlates of Peripartum Transmission of Clade C HIV-1 in the Setting of Peripartum Antiretrovirals.
    Mutucumarana CP; Eudailey J; McGuire EP; Vandergrift N; Tegha G; Chasela C; Ellington S; van der Horst C; Kourtis AP; Permar SR; Fouda GG
    Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28566336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
    Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
    J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mother to child transmission of HIV-1 in a Thai population: role of virus characteristics and maternal humoral immune response.
    Kittinunvorakoon C; Morris MK; Neeyapun K; Jetsawang B; Buehring GC; Hanson CV
    J Med Virol; 2009 May; 81(5):768-78. PubMed ID: 19319941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed generation of antibodies mediating human immunodeficiency virus type 1-specific antibody-dependent cellular cytotoxicity in vertically infected infants. WITS Study Group. Women and Infants Transmission Study.
    Pugatch D; Sullivan JL; Pikora CA; Luzuriaga K
    J Infect Dis; 1997 Sep; 176(3):643-8. PubMed ID: 9291310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission.
    Permar SR; Fong Y; Vandergrift N; Fouda GG; Gilbert P; Parks R; Jaeger FH; Pollara J; Martelli A; Liebl BE; Lloyd K; Yates NL; Overman RG; Shen X; Whitaker K; Chen H; Pritchett J; Solomon E; Friberg E; Marshall DJ; Whitesides JF; Gurley TC; Von Holle T; Martinez DR; Cai F; Kumar A; Xia SM; Lu X; Louzao R; Wilkes S; Datta S; Sarzotti-Kelsoe M; Liao HX; Ferrari G; Alam SM; Montefiori DC; Denny TN; Moody MA; Tomaras GD; Gao F; Haynes BF
    J Clin Invest; 2015 Jul; 125(7):2702-6. PubMed ID: 26053661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mother-to-infant transmission of human immunodeficiency virus type 1: association with prematurity or low anti-gp120.
    Goedert JJ; Mendez H; Drummond JE; Robert-Guroff M; Minkoff HL; Holman S; Stevens R; Rubinstein A; Blattner WA; Willoughby A
    Lancet; 1989 Dec; 2(8676):1351-4. PubMed ID: 2574302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between anti-human immunodeficiency virus type 1 (HIV-1) antibody-dependent cellular cytotoxicity antibody titers at birth and vertical transmission of HIV-1.
    Jenkins M; Landers D; Williams-Herman D; Wara D; Viscarello RR; Hammill HA; Kline MW; Shearer WT; Charlebois ED; Kohl S
    J Infect Dis; 1994 Aug; 170(2):308-12. PubMed ID: 8035015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral phenotype and host-cell susceptibility to HIV-1 infection as risk factors for mother-to-child HIV-1 transmission.
    Ometto L; Zanotto C; Maccabruni A; Caselli D; Truscia D; Giaquinto C; Ruga E; Chieco-Bianchi L; De Rossi A
    AIDS; 1995 May; 9(5):427-34. PubMed ID: 7639967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of virologic and immunologic factors in mother-to-child transmission of HIV-1.
    Colognesi C; Halapi E; Jansson M; Hodara V; Steuer G; Tresoldi E; Leitner T; Scarlatti G
    Am J Reprod Immunol; 1997 Sep; 38(3):197-200. PubMed ID: 9325492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ontogeny of anti-human immunodeficiency virus (HIV) antibody production in HIV-1-infected infants.
    Pollack H; Zhan MX; Ilmet-Moore T; Ajuang-Simbiri K; Krasinski K; Borkowsky W
    Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2340-4. PubMed ID: 8460144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syncytium-inhibiting and neutralizing activity in maternal sera fail to prevent vertical transmission of human immunodeficiency virus type 1.
    Bal AK; Miller G; Viscarello R; Andiman WA
    Pediatr Infect Dis J; 1996 Apr; 15(4):315-20. PubMed ID: 8866800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vertical Transmission of HIV-1. Correlation with maternal viral load and plasma levels of CD4 binding site anti-gp120 antibodies.
    Khouri YF; McIntosh K; Cavacini L; Posner M; Pagano M; Tuomala R; Marasco WA
    J Clin Invest; 1995 Feb; 95(2):732-7. PubMed ID: 7860754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral phenotype in mother-to-child HIV-1 transmission and disease progression of vertically acquired HIV-1 infection.
    De Rossi A; Ometto L; Masiero S; Zanchetta M; Chieco-Bianchi L
    Acta Paediatr Suppl; 1997 Jun; 421():22-8. PubMed ID: 9240853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.